Safety Profile in Long-Term Use Semaglutide has been studied extensively in clinical trials, and its safety profile is well-documented
We have shown that expanded access to GLP-1s to treat obesity yields social returns of up to 20% annually for older populations
Apamin has been shown to block the G0/G1 cell cycle via the PDGF-BB signaling pathway, making it a possible therapy for atherosclerosis (Kim JungYeon et al., 2015)
The benefits go far beyond weight loss, from enhancing fat burning to supporting muscle preservation and even brain health
Never adjust your tirzepatide dosing for weight loss in units without consulting your healthcare provider
Real-Life Case Study: Mark, 38, CrossFit Athlete Mark came to Intra-V with chronic elbow pain that limited his ability to lift, train, and compete